PHASE 2 STUDY OF IRINOTECAN AS THE THIRD LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER (NJLCG0703)K. Watanabe,M. Maemondo, A. Inoue,O. Ishimoto,N. Morikawa,N. Matsubara,T. Sakakibara,T. Fukuhara,S. Sugawara,T. NukiwaANNALS OF ONCOLOGY(2010)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要